PABPC1 and neoplasm: This study revealed the unconventional use of tumorigenic factors such as PABPC1, ENO1, and MSN as extracellular tumor-suppressing proteins, which were enriched in AMPK-inhibited PBMC/lymphocyte-derived CM.